Accueil>>Signaling Pathways>> Ubiquitination/ Proteasome>> DUB>>HBX 41108

HBX 41108

Catalog No.GC12622

HBX 41108 est un inhibiteur non compétitif de la protéase 7 spécifique de l'ubiquitine (USP7) avec une IC50 de 424 nM. HBX 41108 inhibe la désubiquitination de p53 médiée par USP7 pour stabiliser p53 et inhibe la croissance des cellules cancéreuses. HBX 41108 induit une apoptose dépendante de p53 dans les lignées cellulaires cancéreuses isogéniques de type sauvage p53 et nulles.

Products are for research use only. Not for human use. We do not sell to patients.

HBX 41108 Chemical Structure

Cas No.: 924296-39-9

Taille Prix Stock Qté
1mg
28,00 $US
En stock
5mg
126,00 $US
En stock
10mg
207,00 $US
En stock
25mg
486,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

HBX 41108 is a potent inhibitor of USP7 with IC50 value of 424 nM [1].

Ubiquitin-specific-processing protease 7 (USP7) is a ubiquitin specific protease and removes ubiquitin from specific protein substrates. USP7 can deubiquitinate p53, protecting p53 from Mdm2-mediated degradation and involving the oncogenic stabilization of p53.

HBX 41108 is an uncompetitive and reversible USP7 inhibitor. HBX 41108 inhibited USP7-mediated p53 deubiquitination with IC50 value of 0.8 μM in a dose-dependent way and was only weakly active against the aspartic, serine and metalloproteases tested with IC50 > 10 μM. In HCT116 cells, HBX 41108 increased the levels of p53 and p21cip1/waf, which was the product of p53 target genes. In HEK293 cells, HBX 41108 increased the level of polyubiquitinated forms of p53 and reduced Mdm2 levels. In HCT116 colon cancer cells, HBX 41108 inhibited cell proliferation with IC50 value of 1 μM in a dose-dependent way and induced apoptosis in a dose-dependent manner [1]. In COS7 cells, HBX 41108 inhibited PPARγ stability induced by USP7 and decreased the basal transcriptional activity of PPARγ by 70% [2].

References:
[1].  Colland F, Formstecher E, Jacq X, et al. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol Cancer Ther, 2009, 8(8): 2286-2295.
[2].  Lee KW, Cho JG, Kim CM, et al. Herpesvirus-associated Ubiquitin-specific Protease (HAUSP) Modulates Peroxisome Proliferator-activated Receptor γ (PPARγ) Stability through Its Deubiquitinating Activity. J Biol Chem, 2013, 288(46): 32886-32896.

Avis

Review for HBX 41108

Average Rating: 5 ★★★★★ (Based on Reviews and 1 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for HBX 41108

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.